全文获取类型
收费全文 | 56141篇 |
免费 | 6370篇 |
国内免费 | 1461篇 |
专业分类
耳鼻咽喉 | 278篇 |
儿科学 | 1548篇 |
妇产科学 | 1003篇 |
基础医学 | 3059篇 |
口腔科学 | 468篇 |
临床医学 | 4597篇 |
内科学 | 5695篇 |
皮肤病学 | 511篇 |
神经病学 | 1758篇 |
特种医学 | 3936篇 |
外国民族医学 | 74篇 |
外科学 | 4060篇 |
综合类 | 7879篇 |
现状与发展 | 4篇 |
预防医学 | 3679篇 |
眼科学 | 1336篇 |
药学 | 7683篇 |
50篇 | |
中国医学 | 2276篇 |
肿瘤学 | 14078篇 |
出版年
2024年 | 140篇 |
2023年 | 776篇 |
2022年 | 1727篇 |
2021年 | 2317篇 |
2020年 | 2171篇 |
2019年 | 2030篇 |
2018年 | 2111篇 |
2017年 | 2273篇 |
2016年 | 2562篇 |
2015年 | 2367篇 |
2014年 | 3806篇 |
2013年 | 4478篇 |
2012年 | 3568篇 |
2011年 | 3850篇 |
2010年 | 2932篇 |
2009年 | 2638篇 |
2008年 | 2758篇 |
2007年 | 2855篇 |
2006年 | 2572篇 |
2005年 | 2079篇 |
2004年 | 1736篇 |
2003年 | 1531篇 |
2002年 | 1313篇 |
2001年 | 1208篇 |
2000年 | 1004篇 |
1999年 | 888篇 |
1998年 | 676篇 |
1997年 | 690篇 |
1996年 | 531篇 |
1995年 | 550篇 |
1994年 | 496篇 |
1993年 | 385篇 |
1992年 | 317篇 |
1991年 | 292篇 |
1990年 | 260篇 |
1989年 | 239篇 |
1988年 | 193篇 |
1987年 | 199篇 |
1986年 | 154篇 |
1985年 | 248篇 |
1984年 | 215篇 |
1983年 | 167篇 |
1982年 | 142篇 |
1981年 | 121篇 |
1980年 | 110篇 |
1979年 | 91篇 |
1978年 | 59篇 |
1977年 | 52篇 |
1976年 | 43篇 |
1975年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
52.
目的观察WGLY-801型电脑肝病治疗仪对慢性乙型肝炎的治疗效果。方法随机选取慢性乙型肝炎患者144例,分为治疗组66例,在常规治疗基础上加用肝病治疗仪;对照组78例,采用常规治疗,观察两组治疗效果。治疗三疗程共45天(每疗程15天),观察临床症状、肝功能的动态变化,并对最终效果进行评价。结果经治疗后,两组患者临床症状、肝功能较前均有好转,但治疗组起效快,疗程明显缩短,疗效好,差异有明显统计学意义(p<0.05)。结论肝病治疗仪,操作简单,疗效确切,值得进一步推广应用。 相似文献
53.
鼻咽癌高危人群微核特征研究 总被引:1,自引:0,他引:1
目的 观察鼻咽癌高危人群的主要细胞遗传学特征。方法 常规培养外周血淋巴细胞,检测鼻咽癌高危人群、鼻咽癌患者、鼻咽炎患者及正常人的微核率。结果 鼻咽癌高危人群及鼻咽癌患者的微核率明显增加,且随病情进展而继续增高。结论 鼻咽癌高危人群存在比较明确的细胞遗传不稳定性。 相似文献
54.
Aim: To examine the evidence of benefit in initiating immediate chemotherapy in patients with newly diagnosed asymptomatic metastatic incurable cancer, compared with delaying chemotherapy until symptomatic progression. Methods: Through an extensive review of published reports, we examined the biological, clinical, psychological and ethical background of the issue and reported on the available clinical trial evidence in a variety of tumor types. Results: Only a limited number of clinical trials have directly examined the role of immediate versus delayed chemotherapy in patients with incurable asymptomatic metastatic cancer. Small studies in mesothelioma, colorectal cancer, breast cancer, myeloma, and low‐grade lymphoma suggest no survival benefit for the immediate initiation of chemotherapy. However, there was no evidence in other tumor types. Conclusion: The appropriate timing of chemotherapy initiation in an asymptomatic patient with metastatic cancer remains a substantial question in oncology. Many factors are likely to impact on the decision. However, little if any evidence demonstrates a clear advantage in the immediate initiation of chemotherapy in this setting. 相似文献
55.
H. GALLION W.A. CHRISTOPHERSON† R.L. COLEMAN‡ L. DEMARS§ T. HERZOG S. HOSFORD¶ H. SCHELLHAS# A. WELLS & B.-U. SEVIN†† 《International journal of gynecological cancer》2006,16(1):194-201
The study objective was to determine the effectiveness of a phenotypic chemoresponse assay in predicting response to chemotherapy measured by progression-free interval (PFI) in a retrospective series of ovarian cancer patients whose tumor specimens had been tested with the ChemoFx assay. A statistically significant correlation between assay prediction of response and PFI was observed in 256 cases with an exact or partial match between drug(s) assayed and received. In 135 cases with an exact match, the hazard ratio for progression of the resistant group was 2.9 (confidence interval [CI]: 1.4-6.3; P < 0.01) compared to the sensitive group and 1.7 (CI: 1.2-2.5) for the intermediate compared to the sensitive group. The median PFI for patients treated with drugs assayed as resistant was 9 months, 14 months for those with drugs assayed as intermediately sensitive, and PFI had not been achieved for those with drugs assayed as sensitive. These data indicate that the ChemoFx assay is predictive of PFI in ovarian cancer. As the majority of ovarian cancers display different degrees of response to different chemotherapy agents ex vivo, the incorporation of assay information into treatment selection has the potential to improve clinical outcomes in ovarian cancer patients. 相似文献
56.
57.
Rn-222 is the most important source of natural radiation and is responsible for approximately half of the received dose from all sources. Most of this dose is from inhalation of the Rn-222 progeny, especially in closed atmospheres. A Lucas cell technique, using a portable device, “PRASSI” (SILENA mod. 5S), for Rn-222 measurements inside the Centre for Radiation Protection and Radioecology (ZSR), Hannover University was used. The portable radon monitor PRASSI is suitable for radon gas continuous or grab sampling measurements with the scintillation cell technique. In recognition of the wide periodic variations in concentration, measurements were made daily for extended periods. At the same time, meteorological variables, such as temperature and humidity were observed so that their influence on radon levels could be evaluated. The radon average concentration during the year was about 55.9 Bq/m3 which gives rise to an annual effective dose 2.2 mSv y−1. The radon concentration is within the limits prescribed by the International Commission for Radiation Protection. A detailed analysis of radon distribution with seasonal variation is presented. 相似文献
58.
本文通过西宁地区113例住院冠心病人的临床分析,认为西宁地区冠心病患病率低,患者年龄大,男性患病率高于女性,而且绝经期后的高龄女性患者患病率仍然远比男性低,这些与低海拔地区不同。而冠心病各型的分布、临床症状、病死率等与低海拔地区相似。 相似文献
59.
直线加速器十年故障分析总结 总被引:1,自引:0,他引:1
目的分析和总直线加速器十多年来的故障。方法根据十多年来的故障维修记录,统计和分析直线加速器各阶故障率及故障特点。结果直线加速器使用早期由于机器不稳定故障率比较高,使用中期及其比较稳定,故障率比较低,使用后期由于零部件老化,故障率比较高。 相似文献
60.
观察雾化吸入IL-2联合化疗对非小细胞肺癌的临床疗效并与静滴IL-2及单纯化疗进行对比。方法:IL-2的雾化10万u/次,2次/d,连用1月,化疗后3d开始用;IL-2静滴40万u/次,1次/d,加入500ml液体中静滴,连用1月;化疗采用动脉灌注或全身化疗,药物及剂量为环磷酰胺400mg/m2+DDP80mg/m2。结果:用IL-2的两组CR+PR显著高于单纯化疗组(P<0.01);雾化IL-2组CR+PR与静滴IL-2差别无显著性(P>0.05),但不良反应的发生率显著低于后者,而与单纯化疗类似,结论:雾化吸入IL-2联合化疗对非小细胞肺癌有较好的疗效,且副作用小,值得扩大样本进一步验证其疗效。 相似文献